|
Variables
|
HIV status
|
Crude OR (95% CI)
|
Adjusted OR (95% CI)
|
|---|
| |
Positive
|
Negative
| | |
|---|
|
Age at enrolment
| | | | |
|
≤ 6 weeks
|
15
|
338
|
1.0
|
1.0
|
|
> 6 weeks
|
36
|
120
|
6.76 (3.57, 12.79)*
|
2.89 (1.35, 6.21)*
|
|
Sex
| | | | |
|
Male
|
26
|
237
|
0.97 (0.54, 1.73)
|
**
|
|
Female
|
25
|
221
|
1.0
| |
|
Residence
| | | | |
|
Urban
|
27
|
397
|
1.0
|
1.0
|
|
Rural
|
24
|
61
|
5.79 (3.14, 10.67)*
|
5.05 (2.34, 10.9)*
|
|
Place of Birth
| | | | |
|
Health institution
|
33
|
427
|
1.0
|
1.0
|
|
Home
|
18
|
31
|
7.5 (3.81, 14.83)
|
2.82 (1.2, 6.64)
|
|
Maternal status
| | | | |
|
Alive
|
47
|
451
|
1.0
|
**
|
|
Dead
|
4
|
7
|
5.48 (1.55, 19.42)*
| |
|
Maternal PMTCT intervention
| | | | |
|
Yes
|
20
|
397
|
1.0
|
1.0
|
|
No
|
31
|
61
|
10.09 (5.41, 18.82)*
|
5.02 (2.43, 10.4)*
|
|
Infant feeding practice
| | | | |
|
Exclusive breast feeding
|
26
|
371
|
1.0
|
1.0
|
|
Exclusive replacement feeding
|
8
|
59
|
1.94 (0.84,4.48)
|
1.72 (0.65, 4.53)
|
|
Mixed feeding
|
16
|
24
|
9.51 (4.51,20.08)*
|
4.18 (1.59, 10.99)*
|
|
History of infant ARV prophylaxis at birth
| | | | |
|
Received
|
21
|
400
|
1.0
| |
|
Not Received
|
30
|
44
|
12.99 (6.86, 24.6)*
|
**
|
|
Infant ARV prophylaxis during follow up
| | | | |
|
None
|
30
|
45
|
8.22 (2.32, 29.10)*
|
**
|
|
sdNVP
|
5
|
94
|
0.66 (0.15, 2.89)
| |
|
sdNVP + AZT 7 days
|
12
|
265
|
0.56 (0.15, 2.07)
| |
|
sdNVP + AZT 4 weeks
|
3
|
37
|
1.0
| |
|
Baseline Cotrimoxazole
| | | |
**
|
|
Yes
|
44
|
364
|
1.0
| |
|
No
|
7
|
92
|
0.63 (0.28, 1.44)
| |
- *Significant at P-Value <0.05.
- * *non significant from the multivariate logistic regression (Backward LR method).
